Review



cd49d pe cat  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    Miltenyi Biotec cd49d pe cat
    Cd49d Pe Cat, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd49d+pe+cat/LPAM-1+Antibody%2C+anti-mouse%2C+REAfinity/us12345712-1129-95-98
    Average 95 stars, based on 2 article reviews
    cd49d pe cat - by Bioz Stars, 2026-09
    95/100 stars

    Images

    Related Articles

    Binding Assay:

    Article Title: Cancer antigen targets and uses thereof
    Article Snippet: .. In certain embodiments, one or more of the flowing commercially available antibodies can be used for binding to a myeloid/AML antigen: CD70-PE cat. 355104 (Biolegend); EMR2-FITC cat. 130-104-654; EMR2-APC cat. 130-104-656 (Milteny); LTB4R1-AF700 cat. FAB099N; LTB4R1-AF405 cat. FAB099V; LTB4R1-FITC cat. NB100-64832 (Novus Biologicals); LTB4R1-PE cat. FAB099P (R&D); PIEZO1-AF488 cat. NBP11-78537; CD33-APC cat. 551378 (BD Pharmingen); ENG-APC cat. MHCD10505 (Invitrogen); MYADM cat. NBP2-24494SS (Novus); ITGA5 (CD49e)-APC cat. 328011 (Biolegend); SLC19A1-APC cat. FAB8450A (R&D); ILT3-APC (LILRB4) cat. FAB24251A (R&D); CCR1-PE cat. 130-100-368 (Milteniy); ITGA4-APC cat. FAB2450A (R&D); CD49d-PE cat. 130-099-691 (Miltenyi); ICAM1-PE cat. 130-103-909 (Miltenyi); SIRPB1-PE cat. 130-105-310 (Miltenyi); CD64-APC (FCGR1A) cat. 561189 (BD); CD300f (IREM-1)-PE cat. 130-098-472; CD300f (IREM-1)-FITC cat. 130-098-443 (Miltenyi); IL10RB-APC cat. FAB874A (R&D); MRP1-PE cat. IC19291P (R&D); CD38-APC cat. MHCD3805; CD38-PE cat. MHCD3804 (Invitrogen); CD34-APC cat. 340667 (BD); CPM cat. DDX0520P (Dendritics); TTYH3 cat. NBP1-91350 (Novus); SLC NHE1 (SLC9A1) ab58304 (abcam); SLC22A5 bs-8149R (Bioss); KCNN4 PA5-33875 (Thermo Scientific); ITFG3 PA5-31403 (Thermo Scientific); SLC6A6 LS-C179237 (LSBio); SLC43A3 NBP1-85026 (Novus); TFR2 TA504592 (Origene); MBOAT7 NBP1-69610 (Novus); CD235a-APC (GYPA) cat. 551336 (BD Pharmigen); and PLXNC1 cat. AF3887-SP (R&D Systems). ..

    Article Title: Cancer antigen targets and uses thereof
    Article Snippet: .. In certain embodiments, one or more of the flowing commercially available antibodies can be used for binding to a myeloid/AML antigen: CD70-PE cat. 355104 (Biolegend); EMR2-FITC cat. 130-104-654; EMR2-APC cat. 130-104-656 (Milteny); LTB4R1-AF700 cat. FAB099N; LTB4R1-AF405 cat. FAB099V; LTB4R1-FITC cat. NB100-64832 (Novus Biologicals); LTB4R1-PE cat. FAB099P (R&D); PIEZO1-AF488 cat. NBP11-78537; CD33-APC cat. 551378 (BD Pharmingen); ENG-APC cat. NMCD10505 (Invitrogen); MYADM cat. NBP2-24494SS (Novus); ITGA5 (CD49e)-APC cat. 328011 (Biolegend); SLC19A1-APC cat. FAB8450A (R&D); ILT3-APC (LILRB4) cat. FAB24251A (R&D); CCR1-PE cat. 130-100-368 (Milteniy); ITGA4-APC cat. FAB2450A (R&D); CD49d-PE cat. 130-099-691 (Miltenyi); ICAM1-PE cat. 130-103-909 (Miltenyi); SIRPB1-PE cat. 130-105-310 (Miltenyi); CD64-APC (FCGR1A) cat. 561189 (BD); CD300f (TREM-1)-PE cat. 130-098-472; CD300f (TREM-1)-FITC cat. 130-098-443 (Miltenyi); IL10RB-APC cat. FAB874A (R&D); MRP1-PE cat. IC19291P (R&D); CD38-APC cat. MHCD3805; CD38-PE cat. NMCD3804 (Invitrogen); CD34-APC cat. 340667 (BD); CPM cat. DDX0520P (Dendritics); TTYH3 cat. NBP1-91350 (Novus); SLC NHE1 (SLC9A1) ab58304 (abcam); SLC22A5 bs-8149R (Bioss); KCNN4 PA5-33875 (Thermo Scientific); ITFG3 PA5-31403 (Thermo Scientific); SLC6A6 LS-C179237 (LSBio); SLC43A3 NBP1-85026 (Novus); TFR2 TA504592 (Origene); MBOAT7 NBP1-69610 (Novus); CD235a-APC (GYPA) cat. 551336 (BD Pharmigen); and PLXNC1 cat. AF3887-SP (R&D Systems). ..

    Flow Cytometry:

    Article Title: Cancer antigen targets and uses thereof
    Article Snippet: .. Furhtermore, pre-leukemic stem cells model indicated an additional set of surface genes suitable for CAR therapy Materials and Methods Flow-Cytometry We used the following antibodies to define antigen expression by flow-cytometry: CD70-PE cat.355104 (Biolegend); EMR2-FITC cat.130-104-654; EMR2-APC cat. 130-104-656 (Milteny); LTB4R1-AF700 cat.FAB099N; LTB4R1-AF405 cat.FAB099V; LTB4R1-FITC cat.NB100-64832 (Novus Biologicals); LTB4R1-PE cat. FAB099P (R&D) PIEZO1-AF488 cat.NBP11-78537; CD33-APC cat.551378 (BD Pharmingen); ENG-APC cat. MHCD10505 (Invitrogen); MYADM cat.NBP2-24494SS (Novus) ITGA5 (CD49e)-APC cat. 328011 (Biolegend) SLC19A1-APC cat. FAB8450A (R&D) ILT3-APC (LILRB4) cat. FAB24251A (R&D) CCR1-PE cat. 130-100-368 (Milteniy) ITGA4-APC cat. FAB2450A (R&D); CD49d-PE cat. 130-099-691 (Miltenyi) ICAM1-PE cat. 130-103-909 (Miltenyi) SIRPB1-PE cat. 130-105-310 (Miltenyi) CD64-APC (FCGR1A) cat. 561189 (BD) CD300f (IREM-1)-PE cat.130-098-472; CD300f (IREM-1)-FITC cat.130-098-443 (Miltenyi); IL10RB-APC cat. FAB874A (R&D) MRP1-PE cat. IC19291P (R&D) CD38− APC cat. MHCD3805; CD38− PE cat. MHCD3804 (Invitrogen); CD34-APC cat. 340667 (BD) CPM cat.DDX0520P (Dendritics) TTYH3 cat. NBP1-91350 (Novus) SLC NHE1 (SLC9A1) ab58304 (abcam) SLC22A5 bs-8149R (Bioss) KCNN4 PA5-33875 (Thermo Scientific) ITFG3 PA5-31403 (Thermo Scientific) SLC6A6 LS-C179237 (LSBio) SLC43A3 NBP1-85026 (Novus) TFR2 TA504592 (Origene) MBOAT7 NBP1-69610 (Novus) CD235a-APC (GYPA) cat. 551336 (BD Pharmigen) PLXNC1 cat. AF3887-SP (R&D Systems) Vectors Cloning DNMT3a WT, DNMT3a R882H, IDH2 WT, IDH2 R172K, IDH1 WT, IDH1 R132C, IDH1 R132H, IDH2 R140Q, IDH1 R140H were cloned into MIGR1 MSCV GFP vectors. ..

    Expressing:

    Article Title: Cancer antigen targets and uses thereof
    Article Snippet: .. Furhtermore, pre-leukemic stem cells model indicated an additional set of surface genes suitable for CAR therapy Materials and Methods Flow-Cytometry We used the following antibodies to define antigen expression by flow-cytometry: CD70-PE cat.355104 (Biolegend); EMR2-FITC cat.130-104-654; EMR2-APC cat. 130-104-656 (Milteny); LTB4R1-AF700 cat.FAB099N; LTB4R1-AF405 cat.FAB099V; LTB4R1-FITC cat.NB100-64832 (Novus Biologicals); LTB4R1-PE cat. FAB099P (R&D) PIEZO1-AF488 cat.NBP11-78537; CD33-APC cat.551378 (BD Pharmingen); ENG-APC cat. MHCD10505 (Invitrogen); MYADM cat.NBP2-24494SS (Novus) ITGA5 (CD49e)-APC cat. 328011 (Biolegend) SLC19A1-APC cat. FAB8450A (R&D) ILT3-APC (LILRB4) cat. FAB24251A (R&D) CCR1-PE cat. 130-100-368 (Milteniy) ITGA4-APC cat. FAB2450A (R&D); CD49d-PE cat. 130-099-691 (Miltenyi) ICAM1-PE cat. 130-103-909 (Miltenyi) SIRPB1-PE cat. 130-105-310 (Miltenyi) CD64-APC (FCGR1A) cat. 561189 (BD) CD300f (IREM-1)-PE cat.130-098-472; CD300f (IREM-1)-FITC cat.130-098-443 (Miltenyi); IL10RB-APC cat. FAB874A (R&D) MRP1-PE cat. IC19291P (R&D) CD38− APC cat. MHCD3805; CD38− PE cat. MHCD3804 (Invitrogen); CD34-APC cat. 340667 (BD) CPM cat.DDX0520P (Dendritics) TTYH3 cat. NBP1-91350 (Novus) SLC NHE1 (SLC9A1) ab58304 (abcam) SLC22A5 bs-8149R (Bioss) KCNN4 PA5-33875 (Thermo Scientific) ITFG3 PA5-31403 (Thermo Scientific) SLC6A6 LS-C179237 (LSBio) SLC43A3 NBP1-85026 (Novus) TFR2 TA504592 (Origene) MBOAT7 NBP1-69610 (Novus) CD235a-APC (GYPA) cat. 551336 (BD Pharmigen) PLXNC1 cat. AF3887-SP (R&D Systems) Vectors Cloning DNMT3a WT, DNMT3a R882H, IDH2 WT, IDH2 R172K, IDH1 WT, IDH1 R132C, IDH1 R132H, IDH2 R140Q, IDH1 R140H were cloned into MIGR1 MSCV GFP vectors. ..

    Cloning:

    Article Title: Cancer antigen targets and uses thereof
    Article Snippet: .. Furhtermore, pre-leukemic stem cells model indicated an additional set of surface genes suitable for CAR therapy Materials and Methods Flow-Cytometry We used the following antibodies to define antigen expression by flow-cytometry: CD70-PE cat.355104 (Biolegend); EMR2-FITC cat.130-104-654; EMR2-APC cat. 130-104-656 (Milteny); LTB4R1-AF700 cat.FAB099N; LTB4R1-AF405 cat.FAB099V; LTB4R1-FITC cat.NB100-64832 (Novus Biologicals); LTB4R1-PE cat. FAB099P (R&D) PIEZO1-AF488 cat.NBP11-78537; CD33-APC cat.551378 (BD Pharmingen); ENG-APC cat. MHCD10505 (Invitrogen); MYADM cat.NBP2-24494SS (Novus) ITGA5 (CD49e)-APC cat. 328011 (Biolegend) SLC19A1-APC cat. FAB8450A (R&D) ILT3-APC (LILRB4) cat. FAB24251A (R&D) CCR1-PE cat. 130-100-368 (Milteniy) ITGA4-APC cat. FAB2450A (R&D); CD49d-PE cat. 130-099-691 (Miltenyi) ICAM1-PE cat. 130-103-909 (Miltenyi) SIRPB1-PE cat. 130-105-310 (Miltenyi) CD64-APC (FCGR1A) cat. 561189 (BD) CD300f (IREM-1)-PE cat.130-098-472; CD300f (IREM-1)-FITC cat.130-098-443 (Miltenyi); IL10RB-APC cat. FAB874A (R&D) MRP1-PE cat. IC19291P (R&D) CD38− APC cat. MHCD3805; CD38− PE cat. MHCD3804 (Invitrogen); CD34-APC cat. 340667 (BD) CPM cat.DDX0520P (Dendritics) TTYH3 cat. NBP1-91350 (Novus) SLC NHE1 (SLC9A1) ab58304 (abcam) SLC22A5 bs-8149R (Bioss) KCNN4 PA5-33875 (Thermo Scientific) ITFG3 PA5-31403 (Thermo Scientific) SLC6A6 LS-C179237 (LSBio) SLC43A3 NBP1-85026 (Novus) TFR2 TA504592 (Origene) MBOAT7 NBP1-69610 (Novus) CD235a-APC (GYPA) cat. 551336 (BD Pharmigen) PLXNC1 cat. AF3887-SP (R&D Systems) Vectors Cloning DNMT3a WT, DNMT3a R882H, IDH2 WT, IDH2 R172K, IDH1 WT, IDH1 R132C, IDH1 R132H, IDH2 R140Q, IDH1 R140H were cloned into MIGR1 MSCV GFP vectors. ..

    Clone Assay:

    Article Title: Cancer antigen targets and uses thereof
    Article Snippet: .. Furhtermore, pre-leukemic stem cells model indicated an additional set of surface genes suitable for CAR therapy Materials and Methods Flow-Cytometry We used the following antibodies to define antigen expression by flow-cytometry: CD70-PE cat.355104 (Biolegend); EMR2-FITC cat.130-104-654; EMR2-APC cat. 130-104-656 (Milteny); LTB4R1-AF700 cat.FAB099N; LTB4R1-AF405 cat.FAB099V; LTB4R1-FITC cat.NB100-64832 (Novus Biologicals); LTB4R1-PE cat. FAB099P (R&D) PIEZO1-AF488 cat.NBP11-78537; CD33-APC cat.551378 (BD Pharmingen); ENG-APC cat. MHCD10505 (Invitrogen); MYADM cat.NBP2-24494SS (Novus) ITGA5 (CD49e)-APC cat. 328011 (Biolegend) SLC19A1-APC cat. FAB8450A (R&D) ILT3-APC (LILRB4) cat. FAB24251A (R&D) CCR1-PE cat. 130-100-368 (Milteniy) ITGA4-APC cat. FAB2450A (R&D); CD49d-PE cat. 130-099-691 (Miltenyi) ICAM1-PE cat. 130-103-909 (Miltenyi) SIRPB1-PE cat. 130-105-310 (Miltenyi) CD64-APC (FCGR1A) cat. 561189 (BD) CD300f (IREM-1)-PE cat.130-098-472; CD300f (IREM-1)-FITC cat.130-098-443 (Miltenyi); IL10RB-APC cat. FAB874A (R&D) MRP1-PE cat. IC19291P (R&D) CD38− APC cat. MHCD3805; CD38− PE cat. MHCD3804 (Invitrogen); CD34-APC cat. 340667 (BD) CPM cat.DDX0520P (Dendritics) TTYH3 cat. NBP1-91350 (Novus) SLC NHE1 (SLC9A1) ab58304 (abcam) SLC22A5 bs-8149R (Bioss) KCNN4 PA5-33875 (Thermo Scientific) ITFG3 PA5-31403 (Thermo Scientific) SLC6A6 LS-C179237 (LSBio) SLC43A3 NBP1-85026 (Novus) TFR2 TA504592 (Origene) MBOAT7 NBP1-69610 (Novus) CD235a-APC (GYPA) cat. 551336 (BD Pharmigen) PLXNC1 cat. AF3887-SP (R&D Systems) Vectors Cloning DNMT3a WT, DNMT3a R882H, IDH2 WT, IDH2 R172K, IDH1 WT, IDH1 R132C, IDH1 R132H, IDH2 R140Q, IDH1 R140H were cloned into MIGR1 MSCV GFP vectors. ..



    Similar Products

    cd49d pe cat  (Miltenyi Biotec)
    95
    Miltenyi Biotec cd49d pe cat
    Cd49d Pe Cat, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd49d+pe+cat/LPAM-1+Antibody%2C+anti-mouse%2C+REAfinity/us12345712-1129-95-98
    Average 95 stars, based on 1 article reviews
    cd49d pe cat - by Bioz Stars, 2026-09
    95/100 stars
    		  Buy from Supplier

    Image Search Results